theophylline · Baxter Hlthcare · NDA 018649

Theophylline And Dextrose 5% In Plastic Container

Earliest generic entry, as listed · earliest of 7 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 7

NDA · productFormStrengthListed expiry
018649 · 001 · discontinuedinjectable, injection40MG/100MLopen
018649 · 002 · discontinuedinjectable, injection80MG/100MLopen
018649 · 003 · discontinuedinjectable, injection160MG/100MLopen
018649 · 004 · discontinuedinjectable, injection200MG/100MLopen
018649 · 005 · discontinuedinjectable, injection400MG/100MLopen
018649 · 006 · discontinuedinjectable, injection320MG/100MLopen
018649 · 007 · discontinuedinjectable, injection4MG/MLopen